Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 3, May

Spectrum of Radiopharmaceuticals in Nuclear Oncology

Volume:6   Issue: 3
Pp: 181-196
Delphine Denoyer, Nathalie Perek, Nathalie L. Jeune and Francis Dubois
DOI: 10.2174/156800906776842984
Published on: 01 March, 2012

γ-H2AX as a Therapeutic Target for Improving the Efficacy of Radiation Therapy

Volume:6   Issue: 3
Pp: 197-205
J. Kao, M. T. Milano, A. Javaheri, M. C. Garofalo, S. J. Chmura, R. R. Weichselbaum and S. J. Kron
DOI: 10.2174/156800906776842957
Published on: 01 March, 2012

Molecular Targets of Ovarian Carcinomas with Acquired Resistance to Platinum/Taxane Chemotherapy

Volume:6   Issue: 3
Pp: 207-227
Christian Kurzeder, Georg Sauer and Helmut Deissler
DOI: 10.2174/156800906776842975
Published on: 01 March, 2012

Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment

Volume:6   Issue: 3
Pp: 229-244
Xiaohui Zhang, Santo V. Nicosia and Wenlong Bai
DOI: 10.2174/156800906776842939
Published on: 01 March, 2012

Specialisation of the Tropomyosin Composition of Actin Filaments Provides New Potential Targets for Chemotherapy

Volume:6   Issue: 3
Pp: 245-256
Justine R. Stehn, Galina Schevzov, Geraldine M. O'Neill and Peter W. Gunning
DOI: 10.2174/156800906776842948
Published on: 01 March, 2012

Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

Volume:6   Issue: 3
Pp: 257-269
M. M. Marelli, R. M. Moretti, J. Januszkiewicz-Caulier, M. Motta and P. Limonta
DOI: 10.2174/156800906776842966
Published on: 01 March, 2012